Metastatic breast cancer: prolongation of survival in routine care is restricted to hormone-receptor- and Her2-positive tumors
Crossref DOI link: https://doi.org/10.1186/2193-1801-3-535
Published Online: 2014-09-17
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Weide, Rudolf
Feiten, Stefan
Friesenhahn, Vera
Heymanns, Jochen
Kleboth, Kristina
Thomalla, Jörg
van Roye, Christoph
Köppler, Hubert
Text and Data Mining valid from 2014-09-17
Article History
Received: 12 September 2014
Accepted: 12 September 2014
First Online: 17 September 2014